How many institutions held NVCT - Nuvectis Pharma, Inc. - Common Stock, par value $0.00001 per share in Q1 2023?

13 institutional investors reported NVCT - Nuvectis Pharma, Inc. - Common Stock, par value $0.00001 per share for Q1 2023. Use the holders table for investor-level position and value details.

Nuvectis Pharma, Inc. - Common Stock, par value $0.00001 per share (NVCT)

Q: What does CUSIP 67080T108 represent in this 13F holders report?

CUSIP 67080T108 is the security identifier for NVCT - Nuvectis Pharma, Inc. - Common Stock, par value $0.00001 per share used to aggregate holder disclosures.

CUSIP: 67080T108

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Common Stock, par value $0.00001 per share
Total 13F shares: 483,928
Total 13F value: $6,343,634
Share change: -499,997
SEC-reported price per share: $13.11
Number of holders: 13
Value change: -$3,188,708
Number of buys: 11
Number of sells: 3
Shares outstanding: 32,314,196

Security key

67080T108

Report period

Q1 2023

Institutions

Top holders

NVCT full security history Ownership snapshot Full 13F holder table Nuvectis Pharma, Inc. SEC filings Nuvectis Pharma, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NVCT - Nuvectis Pharma, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

SABBY MANAGEMENT, LLC

Disclosed value leader

SABBY MANAGEMENT, LLC

Comparable rows

11/12

Latest evidence

31 Dec 2022

13F 3/4/5 Lead comparable stake: 1.8% 1 rows are not safely comparable across share classes. Showing 1-6 of 12 holder rows.

Quick read

SABBY MANAGEMENT, LLC leads the comparable SEC ownership view at 1.8%.

11 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SABBY MANAGEMENT, LLC's linked filing trail.

Comparable ownership Top 5

SABBY MANAGEMENT, LLC 1.8%

VANGUARD GROUP INC 0.61%

BALDWIN WEALTH PARTNERS LLC/MA 0.41%

GEODE CAPITAL MANAGEMENT, LLC 0.1%

Virtu Financial LLC 0.04%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 12 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
SABBY MANAGEMENT, LLC	13F Company 13F	1.8%	$4,405,890 587,452 shares	—	31 Dec 2022
VANGUARD GROUP INC	13F Company 13F	0.61%	$1,468,718 195,829 shares	—	31 Dec 2022
BALDWIN WEALTH PARTNERS LLC/MA	13F Company 13F	0.41%	$999,750 133,300 shares	—	31 Dec 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.1%	$235,000 31,368 shares	—	31 Dec 2022
Virtu Financial LLC	13F Company 13F	0.04%	$93,000 12,418 shares	—	31 Dec 2022
STATE STREET CORP	13F Company 13F	0.04%	$87,867 11,700 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

483,928

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %